Charity Evans, University of Saskatchewan

Research

Administrative Data Medication Adherence Multiple Sclerosis Pharmacoepidemiology

Latest papers

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
Individualized Physiotherapy and Activity Coaching in Multiple Sclerosis (IPAC-MS): Results of a Randomized Controlled Trial.
Archives of physical medicine and rehabilitation · 2025
Physical Activity in Multiple Sclerosis: Real-World Data From Saskatchewan, Canada.
International journal of MS care · 2025

All 56 publications

Latest funding

Impact of a province-wide initiative to provide free antiretroviral therapy to people living with HIV, a population-based analysis in Saskatchewan
CIHR · 2022 · Co-investigator
$100,000
Medication adherence in multiple sclerosis: a model for other chronic diseases?
CIHR · 2016 · Nominated PI
$282,865

All 2 grants and awards

56 publications.

01

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Kowalec K, Manouchehrinia A, Kingwell E, Carruthers R, Marrie RA, Evans C, Rotstein D, Kuan AJ, Luo W, Luo D, Desrochers B, Jokubaitis VG, Lechner-Scott J, Maltby VE, Groen K, Wright GE, Drögemöller BI, Bernatsky S, Levin MC, Knox K, Maruf AA, Zhong M, Alfredsson L, Hillert J, Kockum I, Olsson T, Stridh P, Shchetynsky K, Dever K, MacIsaac J, Kobor MS, Tremlett H

Multiple sclerosis (Houndmills, Basingstoke, England)2026

DOI: 10.1177/13524585261471335 PMID: 42608789

02

Individualized Physiotherapy and Activity Coaching in Multiple Sclerosis (IPAC-MS): Results of a Randomized Controlled Trial.

Donkers SJ, Evans C, Levin MC, Ives K, Le H, Lim HJ, Knox KB

Archives of physical medicine and rehabilitation2025

DOI: 10.1016/j.apmr.2025.02.005 PMID: 39961428

03

Physical Activity in Multiple Sclerosis: Real-World Data From Saskatchewan, Canada.

Knox KB, Islam A, Le T, Donkers SJ, Evans C, Lim HJ

International journal of MS care2025

DOI: 10.7224/1537-2073.2024-006 PMID: 39931718

04

Anticonvulsant and gabapentinoids pharmacotherapy in the multiple sclerosis prodrome: A population-based matched cohort study.

Bergeron-Vitez H, Yusuf F, Zhu F, Zhao Y, Evans C, Fisk JD, Marrie RA, Kramer JL, Tremlett H

Multiple sclerosis and related disorders2025

DOI: 10.1016/j.msard.2024.106167 PMID: 39616772

05

Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis: A Multiregional Population-Based Study.

Ng HS, Zhu F, Zhao Y, Yao S, Lu X, Ekuma O, Evans C, Fisk JD, Marrie RA, Tremlett H

Neurology2024

DOI: 10.1212/wnl.0000000000208006 PMID: 38181306

06

Participants' perspectives of "NeuroSask: Active and Connect"-a virtual chronic disease management program for individuals with a neurological condition.

Patrick SE, Knox KB, Evans C, Levin M, Linassi G, Poliakov I, Rajput A, Donkers SJ

Frontiers in neurology2024

DOI: 10.3389/fneur.2024.1332859 PMID: 38327624

07

Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study.

Graf J, Ng HS, Zhu F, Zhao Y, Wijnands JM, Evans C, Fisk JD, Marrie RA, Tremlett H

Lancet regional health. Americas2024

DOI: 10.1016/j.lana.2023.100667 PMID: 38269206

08

Gastrointestinal conditions in the multiple sclerosis prodrome.

Yusuf FLA, Zhu F, Evans C, Fisk JD, Zhao Y, Marrie RA, Tremlett H

Annals of clinical and translational neurology2024

DOI: 10.1002/acn3.51945 PMID: 38115680

09

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study.

Graf J, Ng HS, Zhu F, Zhao Y, Wijnands JMA, Evans C, Fisk JD, Marrie RA, Tremlett H

Scientific reports2023

DOI: 10.1038/s41598-023-46313-7 PMID: 38040796

10

Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis.

Chertcoff AS, Yusuf FLA, Zhu F, Evans C, Fisk JD, Zhao Y, Marrie RA, Tremlett H

Neurology2023

DOI: 10.1212/wnl.0000000000207843 PMID: 37748884

Impact of a province-wide initiative to provide free antiretroviral therapy to people living with HIV, a population-based analysis in Saskatchewan

Co-investigatorCIHR2022Project Grant - Priority Announcement: HIV/AIDS and STBBI

Principal investigators: Blackburn, David F; King, Alexandra

Keywords: Antiretroviral Medications; Drug Utilization; Hiv/Aids; Medication Adherence; Medication Cost; Pharmacoepidemiology

$100,000

Medication adherence in multiple sclerosis: a model for other chronic diseases?

Nominated PICIHR2016Project Grant

Principal investigators: Evans, Charity D; Marrie, Ruth Ann

Keywords: Administrative Data; Medication Adherence; Multiple Sclerosis; Pharmacoepidemiology

$282,865

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine/Neurology
Medicine
Family Medicine
College of Pharmacy
Community Health Sciences
Clinical Epidemiology
Anesthesiology, Pharmacology and Therapeutics
Other

Applying for

Paper to mention

Subject: Prospective PhD student: Administrative Data Dear Professor Evans, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Charity Evans

Research

Latest papers

Latest funding

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Individualized Physiotherapy and Activity Coaching in Multiple Sclerosis (IPAC-MS): Results of a Randomized Controlled Trial.

Physical Activity in Multiple Sclerosis: Real-World Data From Saskatchewan, Canada.

Anticonvulsant and gabapentinoids pharmacotherapy in the multiple sclerosis prodrome: A population-based matched cohort study.

Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis: A Multiregional Population-Based Study.

Participants' perspectives of "NeuroSask: Active and Connect"-a virtual chronic disease management program for individuals with a neurological condition.

Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a&#xa0;population-based study.

Gastrointestinal conditions in the multiple sclerosis prodrome.

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study.

Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis.

Impact of a province-wide initiative to provide free antiretroviral therapy to people living with HIV, a population-based analysis in Saskatchewan

Medication adherence in multiple sclerosis: a model for other chronic diseases?

Frequent collaborators

Helen Tremlett

Charity Evans

David Blackburn

Gary Teare

Anthony Traboulsee

Andrea Iaboni

Andrea Gruneir

Kaarina Kowalec

Andrea Gruneir

Lisa Lix

Nicole Mittmann

Kaarina Kowalec

Tara Gomes

Sharyle Fowler

Colin Dormuth

Kirsten Fiest

Thomas Rotter

Mina Tadrous

Paul Khairy

Christel Renoux

Sasha Bernatsky

Thomas Hadjistavropoulos

Joanne Ho

Russell Steele

Connie Marras

Lucie Blais

Sasha Bernatsky

Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study.